$PCTL News PCT LTD Reports Installations of Annihi
Post# of 36900
(Total Views: 42)
Posted On: 12/17/2020 9:28:29 AM
$PCTL News PCT LTD Reports Installations of Annihilyzer® Hospital Equipment and Provides Update on Current Share Structure
Thu, December 17, 2020, 8:15 AM EST
PCT LTD (OTC Pink: PCTL) reports the successful installation of four rack-mounted Annihilyzer® systems in another new NYC hospital through the efforts of the Company’s distributor, ACE Janitorial. In addition, two more Annihilyzer® systems are slated for installation in another NYC hospital at the beginning of 2021.
The newly installed Annihilyzer® systems are providing hospitals and the healthcare industry at large with cutting edge disinfecting and decontaminating solutions that combat microbial infection during this global pandemic.
PCT LTD CEO, Gary Grieco, stated, "We are proud to be filling the growing demand of our products to hospitals in New York City. We are prepared to ship and install more Annihilyzer® equipment now and into the new year."
PCTL is also providing an update to shareholders on the outstanding number of shares of its Common Stock. The actual number of outstanding shares was 721,187,846, of which 126,187,846 shares were restricted, as of November 30, 2020.
Gary Grieco, PCTL’s CEO, commented, "In response to incoming questions, we acknowledge that we may have caused some confusion by making close estimates of the outstanding shares reported in our press release and subsequent 8-K. The intent was to get important information out quickly about settling previous variable rate convertible notes." Grieco further stated, "In addition to the updates announced in this release, there are many other activities occurring that will likely play an exciting role in PCTL’s record-setting 4th quarter."
About PCT Ltd:
PCT LTD ("PCTL"
focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC
INK, "PCTL" continues to be actively engaged in applying for listing its common stock to the OTC QB market. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
ADDITIONAL NEWS AND CORPORATE UPDATES:
PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC. PCTL does not utilize social media, chatrooms or other online sources to disclose material information. The public should only rely on official press releases and corporate filings for accurate and up to date information regarding PCTL.
Forward-Looking Statements:
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the ability of PCTL to fulfill equipment orders; PCTL's continued installation of equipment; subsequent installations of PCTL's Annihilyzer Infection Control Systems and other larger-volume equipment; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005288/en/
Contacts
Gary Grieco, CEO and Chairman, PCT LTD
+1(843) 390-7900 Office
www.para-con.com
www.pctcorphealth.com
www.survivalyte.com
Rich Inza, Investor Relations (RMJ Consulting, LLC)
+1(843) 491-4611
IR@para-con.com
Dave Donlin, Investor Relations (The Cervelle Group)
(407) 405-8142
Thu, December 17, 2020, 8:15 AM EST
PCT LTD (OTC Pink: PCTL) reports the successful installation of four rack-mounted Annihilyzer® systems in another new NYC hospital through the efforts of the Company’s distributor, ACE Janitorial. In addition, two more Annihilyzer® systems are slated for installation in another NYC hospital at the beginning of 2021.
The newly installed Annihilyzer® systems are providing hospitals and the healthcare industry at large with cutting edge disinfecting and decontaminating solutions that combat microbial infection during this global pandemic.
PCT LTD CEO, Gary Grieco, stated, "We are proud to be filling the growing demand of our products to hospitals in New York City. We are prepared to ship and install more Annihilyzer® equipment now and into the new year."
PCTL is also providing an update to shareholders on the outstanding number of shares of its Common Stock. The actual number of outstanding shares was 721,187,846, of which 126,187,846 shares were restricted, as of November 30, 2020.
Gary Grieco, PCTL’s CEO, commented, "In response to incoming questions, we acknowledge that we may have caused some confusion by making close estimates of the outstanding shares reported in our press release and subsequent 8-K. The intent was to get important information out quickly about settling previous variable rate convertible notes." Grieco further stated, "In addition to the updates announced in this release, there are many other activities occurring that will likely play an exciting role in PCTL’s record-setting 4th quarter."
About PCT Ltd:
PCT LTD ("PCTL"
focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC INK, "PCTL" continues to be actively engaged in applying for listing its common stock to the OTC QB market. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K. ADDITIONAL NEWS AND CORPORATE UPDATES:
PCTL would like to warn its stockholders and potential investors that material corporate information regarding sales, areas of business and other corporate updates will only be made through press releases or filings with the SEC. PCTL does not utilize social media, chatrooms or other online sources to disclose material information. The public should only rely on official press releases and corporate filings for accurate and up to date information regarding PCTL.
Forward-Looking Statements:
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements."
Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: the ability of PCTL to fulfill equipment orders; PCTL's continued installation of equipment; subsequent installations of PCTL's Annihilyzer Infection Control Systems and other larger-volume equipment; PCTL's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCTL to execute its business plan; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCTL makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the SEC. PCTL undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201217005288/en/
Contacts
Gary Grieco, CEO and Chairman, PCT LTD
+1(843) 390-7900 Office
www.para-con.com
www.pctcorphealth.com
www.survivalyte.com
Rich Inza, Investor Relations (RMJ Consulting, LLC)
+1(843) 491-4611
IR@para-con.com
Dave Donlin, Investor Relations (The Cervelle Group)
(407) 405-8142
(0)
(0)Scroll down for more posts ▼